Related references
Note: Only part of the references are listed.The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR
Li Bai et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance
Ian M. Gould et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor
Onisha Patel et al.
NATURE IMMUNOLOGY (2012)
Immunomodulatory Type II Natural Killer T Lymphocytes in Health and Disease
S. Rhost et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Sulfatide-Mediated Activation of Type II Natural Killer T Cells Prevents Hepatic Ischemic Reperfusion Injury In Mice
Philomena Arrenberg et al.
GASTROENTEROLOGY (2011)
New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis
Reetta Huttunen et al.
JOURNAL OF INFECTION (2011)
The Combination of a Tumor Necrosis Factor Inhibitor and Antibiotic Alleviates Staphylococcal Arthritis and Sepsis in Mice
Ying Fei et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
NKT Cells: The Culprits of Sepsis?
Briana Leung et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Presumed guilty: natural killer T cell defects and human disease
Stuart P. Berzins et al.
NATURE REVIEWS IMMUNOLOGY (2011)
In Vivo Protection Provided by a Synthetic New Alpha-Galactosyl Ceramide Analog against Bacterial and Viral Infections in Murine Models
Kun-Hsien Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Gram-Positive and Gram-Negative Bacteria Induce Different Patterns of Cytokine Production in Human Mononuclear Cells Irrespective of Taxonomic Relatedness
Susann Skovbjerg et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis
Marcin Klak et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells
Maria Blomqvist et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The Role of Hepatic Invariant NKT Cells in Systemic/Local Inflammation and Mortality during Polymicrobial Septic Shock
Caroline K. Hu et al.
JOURNAL OF IMMUNOLOGY (2009)
Staphylokinase reduces plasmin formation by endogenous plasminogen activators
Tao Jin et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis
Anthony O. Etogo et al.
JOURNAL OF IMMUNOLOGY (2008)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis
Elena Ambrosino et al.
JOURNAL OF IMMUNOLOGY (2007)
Type IINKT cell-mediated anergy induction in type INKT cells prevents inflammatory liver disease
Ramesh C. Halder et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
Jeffrey R. Curtis et al.
ARTHRITIS AND RHEUMATISM (2007)
The unique role of natural killer T cells in the response to microorganisms
Emmanuel Tupin et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Activation of natural killer T cells by α-galactosylceramide mediates clearance of bacteria in murine urinary tract infection
S Minagawa et al.
JOURNAL OF UROLOGY (2005)
An essential role for tumor necrosis factor in the formation of experimental murine Staphylococcus aureus-induced brain abscess and clearance
W Stenzel et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide
A Jahng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety
KL Hyrich et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Sepsis as a possible adverse drug reaction in patients with rheumatoid arthritis treated with TNFα antagonists
A Kling et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2004)
Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia
JM Querol-Ribelles et al.
CHEST (2004)
Role of CD1d-restricted NKT cells in microbial immunity
M Sköld et al.
INFECTION AND IMMUNITY (2003)
β2 microglobulin knockout mice are resistant to lethal intraabdominal sepsis
ER Sherwood et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Novel strategies for the treatment of sepsis
NC Riedemann et al.
NATURE MEDICINE (2003)
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management
MA Gardam et al.
LANCET INFECTIOUS DISEASES (2003)
Inhibition of CD1d activation suppresses septic mortality: A role for NK-T cells in septic immune dysfunction
RJ Rhee et al.
JOURNAL OF SURGICAL RESEARCH (2003)
Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients
J Raaphorst et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Model systems: Modeling human staphylococcal arthritis and sepsis in the mouse
A Tarkowski et al.
TRENDS IN MICROBIOLOGY (2001)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction
F Dieli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions
SM Behar et al.
SEMINARS IN IMMUNOLOGY (2000)
Share Paper
